A Structured–Activity Relationship Study of Batracylin Analogues

Yilin Luo; Yun Feng Ren; Ting Chao Chou; Allan Y. Chen; Chiang Yu; Leroy F. Liu; C. C. Cheng

doi:10.1023/A:1018929815422

A Structured–Activity Relationship Study of Batracylin Analogues

Yilin Luo
, Yun Feng Ren
, Ting Chao Chou
, Allan Y. Chen
, Chiang Yu
, Leroy F. Liu
, C. C. Cheng

Research output: Contribution to journal › Article › peer-review

30 Citations (Scopus)

Abstract

A number of isoindolo[l ,2- b]quinazolines and some benzo[4,5]isoquinolino[l,2- b]quinazolines as structural modification analogues of the antitumor compound batracylin were synthesized and evaluated against HL-60 cell growth and in topoisomerase II-mediated DNA cleavage assays. Of the compounds studied, 10,12-dihydro-7,8-methy lenedioxyisoindolo[ 1,2- b] quinazolin-12(10 H)-one 1d, 2-amino-10,12-dihydroisoindolo[l ,2- b]quinazolin- 12(10 H)-one 1p, and 2-amino-7,8-methylenedioxy-10,12-dihydroisoindolo[l ,2- b]quinazolin-12(10 H)-one 1ab exhibited good inhibitory activities against HL-60 cell lines as well as induction of topo II-mediated DNA cleavage activities.

Original language	English
Pages (from-to)	918-923
Number of pages	6
Journal	Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists
Volume	10
Issue number	6
DOIs	https://doi.org/10.1023/A:1018929815422
Publication status	Published - Jun 1993
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

DNA topoisomerase
colon adenocarcinoma 38
cytotoxicity
isoindolo[l,2- b]quinazolines
structure–activity relationship

ASJC Scopus subject areas

Pharmacology (medical)
Molecular Medicine
Biotechnology
Pharmacology
Pharmaceutical Science
Organic Chemistry

Access to Document

10.1023/A:1018929815422

Cite this

@article{8a5a7f74a3714470886a274f7fb41740,

title = "A Structured–Activity Relationship Study of Batracylin Analogues",

abstract = "A number of isoindolo[l ,2- b]quinazolines and some benzo[4,5]isoquinolino[l,2- b]quinazolines as structural modification analogues of the antitumor compound batracylin were synthesized and evaluated against HL-60 cell growth and in topoisomerase II-mediated DNA cleavage assays. Of the compounds studied, 10,12-dihydro-7,8-methy lenedioxyisoindolo[ 1,2- b] quinazolin-12(10 H)-one 1d, 2-amino-10,12-dihydroisoindolo[l ,2- b]quinazolin- 12(10 H)-one 1p, and 2-amino-7,8-methylenedioxy-10,12-dihydroisoindolo[l ,2- b]quinazolin-12(10 H)-one 1ab exhibited good inhibitory activities against HL-60 cell lines as well as induction of topo II-mediated DNA cleavage activities.",

keywords = "DNA topoisomerase, colon adenocarcinoma 38, cytotoxicity, isoindolo[l,2- b]quinazolines, structure–activity relationship",

author = "Yilin Luo and Ren, \{Yun Feng\} and Chou, \{Ting Chao\} and Chen, \{Allan Y.\} and Chiang Yu and Liu, \{Leroy F.\} and Cheng, \{C. C.\}",

year = "1993",

month = jun,

doi = "10.1023/A:1018929815422",

language = "English",

volume = "10",

pages = "918--923",

journal = "Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists",

issn = "0724-8741",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - A Structured–Activity Relationship Study of Batracylin Analogues

AU - Luo, Yilin

AU - Ren, Yun Feng

AU - Chou, Ting Chao

AU - Chen, Allan Y.

AU - Yu, Chiang

AU - Liu, Leroy F.

AU - Cheng, C. C.

PY - 1993/6

Y1 - 1993/6

N2 - A number of isoindolo[l ,2- b]quinazolines and some benzo[4,5]isoquinolino[l,2- b]quinazolines as structural modification analogues of the antitumor compound batracylin were synthesized and evaluated against HL-60 cell growth and in topoisomerase II-mediated DNA cleavage assays. Of the compounds studied, 10,12-dihydro-7,8-methy lenedioxyisoindolo[ 1,2- b] quinazolin-12(10 H)-one 1d, 2-amino-10,12-dihydroisoindolo[l ,2- b]quinazolin- 12(10 H)-one 1p, and 2-amino-7,8-methylenedioxy-10,12-dihydroisoindolo[l ,2- b]quinazolin-12(10 H)-one 1ab exhibited good inhibitory activities against HL-60 cell lines as well as induction of topo II-mediated DNA cleavage activities.

AB - A number of isoindolo[l ,2- b]quinazolines and some benzo[4,5]isoquinolino[l,2- b]quinazolines as structural modification analogues of the antitumor compound batracylin were synthesized and evaluated against HL-60 cell growth and in topoisomerase II-mediated DNA cleavage assays. Of the compounds studied, 10,12-dihydro-7,8-methy lenedioxyisoindolo[ 1,2- b] quinazolin-12(10 H)-one 1d, 2-amino-10,12-dihydroisoindolo[l ,2- b]quinazolin- 12(10 H)-one 1p, and 2-amino-7,8-methylenedioxy-10,12-dihydroisoindolo[l ,2- b]quinazolin-12(10 H)-one 1ab exhibited good inhibitory activities against HL-60 cell lines as well as induction of topo II-mediated DNA cleavage activities.

KW - DNA topoisomerase

KW - colon adenocarcinoma 38

KW - cytotoxicity

KW - isoindolo[l,2- b]quinazolines

KW - structure–activity relationship

UR - https://www.scopus.com/pages/publications/0027322883

UR - https://www.scopus.com/pages/publications/0027322883#tab=citedBy

U2 - 10.1023/A:1018929815422

DO - 10.1023/A:1018929815422

M3 - Article

C2 - 8391697

AN - SCOPUS:0027322883

SN - 0724-8741

VL - 10

SP - 918

EP - 923

JO - Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists

JF - Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists

IS - 6

ER -

A Structured–Activity Relationship Study of Batracylin Analogues

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this